News
In this work, we introduce Log(v) 3LPF, a linear power flow solver for unbalanced three-phase distribution systems. Log(v) 3LPF uses a logarithmic transform of the voltage phasor to linearize the AC ...
A unified theory of coupled photo-thermoelasticity is defined to investigate both delay phase-lag times of the temperature gradient and the heat flux as well as the third delay phase-lag time of the ...
Pyrolysis of wet sewage sludge with a moisture of 86.47 wt % was conducted using electric heating (conventional pyrolysis, CP) and microwave heating (microwave pyrolysis, MWP) separately on two sets ...
In potential good news for Prothena, Roche announced earlier this week that it will advance Prothena-partnered prasinezumab into phase 3 trials for early-stage Parkinson’s disease, despite the ...
Inductive wireless power transfer (IPT) has brought convenience to many aspects of human life. Three-phase IPT has been proven with better performance in high-power applications. Three-phase IPT coil ...
The Las Vegas Raiders have several new pieces on their coaching staff and roster this season, but the Raiders' well-respected special teams coordinator, Tom McMahon returns.
The Las Vegas Raiders have several new pieces on their coaching staff and roster this season, but the Raiders' well-respected special teams coordinator, Tom McM ...
With what Insmed calls an "outstanding" phase 2 win for its treprostinil palmitil inhalation powder (TPIP) in patients with pulmonary arterial hypertension (PAH), the company is racing to phase 3 a ...
JERUSALEM — Israel and Germany have started preparations to deliver the the Arrow-3 missile shield to German forces in the coming months, the Israeli Ministry of Defense announced. According to ...
Otsuka Pharmaceutical has shared more detailed data behind its kidney disease drug’s phase 3 win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio (UPCR) levels.
In the Phase 3 VISIONARY study, sibeprenlimab achieved a statistically significant and clinically meaningful 51.2% (P<0.0001) reduction in proteinuria at nine months of treatment when compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results